All filters
Slidesets
Integration of Hepatitis C Treatment Services with Harm Reduction Service Centers for People who Inject Drugs in Kenya: Experience from Test and Link to Care for Injecting Drug Users Study- M. Nyakowa
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
Towards the Elimination of HCV in British Columbia: A strategy to Address the “messy middle”- B. Conway
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
Real-World Challenges to and Opportunities for Microelimination in Two Remote Communities in Northwestern Ontario- D. Smookler
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
Policy Implementation Index Based off of Patient Reported Outcomes: The Hep-CORE Study- A. Palayew
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
Mongolia’s Model for Care- Naranjargal Dashdorj, MD, PhD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
Hepatitis C Elimination in the Netherlands (CELINE): a Nationwide Study Retrieving Lost to Follow-Up Chronic Hepatitis C Patients- M. Van Dijk
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
Oral Prescription Opioid Use should be Considered a Risk Factor for HCV Infection: Another Step Toward HCV Elimination- B. Hack
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
The ABC of viral hepatitis- Mark Thursz, MRCP
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Burden of Liver Disease in North Africa- Ayman Yosry
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Clinical spectrum of liver disease in Africa- Wendy Spearman, MBChB, FCP, FRCP, MMed, PhD
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
The global challenge of viral hepatitis- Olufunmilayo Lesi, MD, MBA, FMCP, FWACP
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Hepatitis D - a forgotten foe?- Richard Njouom, PhD
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Hepatitis B stigma by association with HIV in Zambia- Michael Vinikoor
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Prevalence estimates of chronic hepatitis B virus infection: a comparative study of four sources and implications for burden assessment in sub-Saharan Africa- Nora Schmit
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Epidemiology of hepatitis B and evaluation of vaccine efficacy in a census-based community serosurvey of Ndirande township in Blantyre, Malawi- Alexander Stockdale
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Hepatitis B screening and prevention integration into ante-natal care and delivery services in an urban cohort in Mozambique- Natalia Tamayo Antabak
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Population-based evaluation of hepatitis B markers and criteria for antiviral therapy in Lusaka Province, Zambia- Michael Vinikoor
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Treatment of chronic hepatitis B in sub-Saharan Africa: 3-year results of a pilot program in Ethiopia- Asgeir Johannessen
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Characterization of Hepatitis B Virus (HBV) Among Liver Patients in Kenya- Missiani Ochwoto
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Prevalence of HBV and HCV infections in screened people in Rwanda during WHD 2017 campaign- Jean Damascene Makuza
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
HCV diagnosis and direct-acting antiviral agents -based treatment for HIV/HCV co-infected patients in a primary care setting in Maputo, Mozambique- Natalia Tamayo Antabak
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018